aal investment forum 2010 - life sciences and ict from a vc point of view
DESCRIPTION
Dr. Nissim Darvish, Orbimed Advisors, Israelhttp://www.aal-invest.eu/page/speaker-profiles-nisTRANSCRIPT
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
1
This document does not constitute an offer of securities. Such an offer will only be made by means of a Confidential Memorandum to be furnished to investors at a later date. The manager may make changes to this document without notification.
Click to edit Master subtitle style
Life Sciences and ICT from a VC point of view
Nissim Darvish, MD, Ph.D.,Senior Managing Director
Odense Denmark
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
2
The Communications Revolution
TelegraphyMorse (1873)Telephon
yBell (1876)
WirelessMarconi (1896)
Cellular Bell Labs (1972)
InternetARPANET (1970)
World Wide WebNASA Illinois (1993)
2010
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
3
e-Health-or the Marriage of ICT and Healthcare: The HICT
• e-health = Healthcare practice which is supported by electronic
• processes and communication (Source: Wikipedia)
• ICT can improve the speed and the automation of the information management (capturing, transmission , processing and storage) in a secure, scalable and efficient way.
1. Better quality of care2. More efficient use of scarce resources (1)3. Better quality of life patients4. Better quality of life Healthcare professionals5. Better Financials
HICT can be translate
1 Redundancy and inefficiency account for 25-40% of cost (eHealth taskforce report 2007-EC)
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
4
HCIT Drivers Du Jour
• The Patient/Consumer pressure will dramatically change the delivery of healthcare
• The abundance of information and data will have to be organized in a useful way for decision support for medical staff and patients
• Medical knowledge and medical decisions have to be available in primary care/home settings and at the point of care
• Integrated care with the emphasis on systems of care ex. Kaiser, in the US and Torbay in the UK to compete with other Integrated care givers
• The need for increasing healthcare provider efficiency and reducing cost
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
5
HCIT-Basket of applications
Monitoring
Asset Management
Patient Records
Medical Equipment
Disease Management
E-PharmaHCIT
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
6
Entrepreneurs – Venture Capital
Entrepreneurs create and build value based on opportunity and personal motivation to innovate.
Venture capitalists provide the currency for entrepreneurs to build theirideas into valuable companies
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
7
Entrepreneurs – Venture Capital
VCs are RETURN SENSETIVE
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
8
VC Lifescience Investment 1995-2010 YTD
1.72.4
3.2 3.5
4.7
7.5
5.75.3 5.3
6.3 6.4
7.7
9.1
8
6.2
3.4
0
1
2
3
4
5
6
7
8
9
10
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
Year
$Bill
ion
0
5
10
15
20
25
30
35
40
% L
S
Series2 Series1
Series2 1.7 2.4 3.2 3.5 4.7 7.5 5.7 5.3 5.3 6.3 6.4 7.7 9.1 8 6.2 3.4
Series1 24 23 23 18 9 8 15 26 28 29 28 29 30 28 34 30
Year
YTD
$Billion % from Total VC
Money Tree Data
$B
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
9
HCIT and Related Services Private Capital Raising
Only10% of the investments in LS go to HCIT
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
10
HCIT Market
• The healthcare information technology market is estimated to be $53.8 billion by 2014, growing at a CAGR of 16.1%. The market is expected to grow mainly due to:
• electronic medical records,• electronic health records• computerized physician order entry system• Non clinical systems.
The main driving element for global healthcare information technology market is the changing government regulationsand government initiatives tobring down the healthcare costs.
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
11
The 3P model for HCIT Investment
Patients Physicians/ Practitioners
Processes
The three fundamental elements of healthcare ICT investment: practitioners, patients, and processes. All three are of equal importance and should be prerequisites to funds HCIT.
•Adapted from Cisco Internet Business Solutions Group
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
12
HCIT-Basket of applications
Monitoring
Asset Management
Patient Records
Medical Equipment
Disease Management
E-PharmaHCIT
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
13
Patient Records- Electronic Records
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
14
94 93 9284
7673 72
66 65 6459
5447
3227
21 20 18
11 8 3
66
5956
77
10095 94
72
81
0102030405060708090
100
FI UK EE NL
NO DK IS IT BG BE
SK FR DE ES
EU27 HU PT CZ
LU IE AT
SE CY
MT
RO EL SI PL LT LV
EU GPs using a computer during consultation, in % (EC Study 2007)
Source: empirica: ICT and eHealth use among GPs in Europe 2007, Bonn April 2008
Random samples of 6,789 GPs in 29 countries
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
15
% GPs Connected to Secondary Healthcare(hospitals and/or specialist)
0
10
20
30
40
50
60
70
80
90
100
EU27 BE BG CZ DK DE EE EL ES FR IE IT CY LV LT LU HU MT NL AT PL PT RO SISK FI
SE UK IS NO
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
16
% Connectivity to Health Authorities
Health authorities
64
51
29
2116 15 13 13 13 11 11 11
7 7 7 5 5 5 4 4 3 3 110 9
1817 17
78
1318
0
10
20
30
40
50
60
70
80
90
100
EU
27
EU
27+
2
EE
DK
UK LT IT PT
FR IS SI
ES PL
NO IE AT
MT FI
BE
SE
BG
RO NL
LV CZ
LU HU
DE
SK
CY
EL
Source: empirica: ICT and eHealth use among GPs in Europe 2007, Bonn April 2008
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
17
% Link to insurers (reimbursers)
Admin data with reimbursers routinely
45 43
2623
1915 14
10 8 8 5 5 4 3 3 3 3 2 2 1 1 0 05 4
1915 15
48
13
21
0
10
20
30
40
50
60
70
80
90
100
EU
27
EU
27+2 DK NL
UK
FR PL LT AT
NO IE SI
CZ
BG SE FI EE PT
HU SK
DE
MT
CY EL BE
ES
RO IT IS LV LU
Source: empirica: ICT and eHealth use among GPs in Europe 2007, Bonn April 2008
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
18
For HCIT – Electronic Records to work ? •Infrastructure and Technical challenges
• Secure/reliable wireless connection• Battery
•Errorless sensors •Business model •Cost•Interoperability•Privacy and confidentiality•Workforce •Incentive: Doctors/patients/payers/hospitals •Government priorities are driving the change
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
19
HCIT Median Deal Valuation
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
20
Medical Equipment – Medical Devices
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
21
Wireless Medical Devices
Patient Web Viewer
Physician
Monitoring CenterWireless LAN
Cellular
Proprietary
DECT
ECGTempBlood PressureWeightGlucose Oxy meterSwallowable pill
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
22
In-stent Stenosis
• Self Monitoring Stent: Detect restenosis
Measure Blood Pressure Continuously
Yogesh Gianchandani and his team at the University of MichiganReport #C245, "Worldwide Coronary Stents Market, 2008-2017," published May 2009 by MedMarket
Diligence.
Worldwide Coronary Stents Market
2.5
5.0
7.5
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
23
Closed Loop Devices
• Automatic dosing control based upon measured result• Improved accuracy• Benefits also to pharmaceutical trials
ApplicationsAsthma flow meter / inhalerDiabetes glucose meter /injection devicesCardiac Rhythm management
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
24
Key Healthcare Industry Segments
Medical Devices Pharma/Biotech HC Services and HCIT
% Volume ($)1997-2010
18% 72% HC-Services 8%E-Health 2%
Drivers for M&A – Rise of emerging markets; areas for growth and low cost manufacturing– Acquisition to extend core competencies
– Expiring drug patents– Increasing demand for products, services and technology from emerging markets– Global competition
– Regional consolidation– Huge demand for quality healthcare and increased healthcare spending
Level ofConsolidation
Moderately fragmented With the 50 largest Companies generating 60% of total market revenue
Highly concentrated withover 50% of the market held by 15 multinationalcompanies
Highly fragmented with the 50 largest companies generating only 15% of total market revenue
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
25
Healthcare M&A 2007-2009
M&A International Inc report , Fall 2009
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
26
Ageing and ICT
• Social• • 80+ population: doubles until 2050• • 60+ population: from 20% in 1995 to 25% in 2020• • 50+ population: 21% has severe vision/hearing/dexterity problems• • Today 4 working for 1 retired, in 2050 only 2 working for 1 retired• • Cost of pensions/health/long-term care: up by 4-8 % of GDP (2025)• • Shortfall of care staff
Economy • • Wealth and revenues in Europe of persons over 65 is over 3000 B€• • Smart homes market will triple between 2005 and 2020• • Early patient discharge by tele-health: reduced cost of 1,5 B€ p.a. (DE)• • Tele-care technology at home: Empowerment of elderly and efficiency • gains of 25% (UK)• • Telecare market >5 B€/year by 2015 in Europe
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
27
Summary
The healthcare IT is dynamic growing sectorIT solutions can radically improve efficiency
and productivity There are different segments within HCIT, each one of this sector possess different value and challenges
In the future, we expect to see:– Greater levels of integration between devices– An increasing presence of ‘application
services’– Increasing use of implantable medical
devices; therapeutic, monitor and diagnostic
© 2010 OrbiMed Advisors, LLC. All Rights Reserved. CONFIDENTIAL
28
This document does not constitute an offer of securities. Such an offer will only be made by means of a Confidential Memorandum to be furnished to investors at a later date. The manager may make changes to this document without notification.
Click to edit Master subtitle style
Nissim Darvish, MD, Ph.D.,Senior Managing Director
Odense Denmark